The memory of Fukushima Daiichi nuclear disaster is still clear. People are still worried about food coming from Japan are contaminated by radiation. However, several years after the disaster, the radiation level in Tokyo today is actually lower than Paris.
Neupogen® is an existing drug approved in 1991 to treat cancer patients receiving chemotherapy. Dr. Thomas J. MacVittie and Dr. Ann M. Farese at University of Maryland School of Medicine Department of Radiation Oncology’s Division of Translational Radiation Sciences continued to research and find the drug is able to protect blood cells which treat acute radiation injury. The drug was approved by U.S. Food and Drug Administration, and became the first radiation treatment drug.
I guess most countries with nuclear plants will stock up the drug, while Amgen, who produced the drug, is laughing its way to the bank.